Skip to main content
Clinical Trials/NCT02369224
NCT02369224
Completed
Not Applicable

Multicenter Validation of The Evergreen Myometric Strength Test for Lower Extremities (EMST-LE) in Multiple Sclerosis: Protocol for Strength Testing and Reliability Characteristics

Brown, Theodore R., M.D., MPH1 site in 1 country27 target enrollmentJanuary 2015

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Multiple Sclerosis
Sponsor
Brown, Theodore R., M.D., MPH
Enrollment
27
Locations
1
Primary Endpoint
To assess the intra-rater and inter-rater reliability of a hand-held dynamometer (HHD) in the assessment of lower extremity strength in patients with multiple sclerosis
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

A Cross- Sectional study; To assess the intra-rater and inter-rater reliability of a hand-held dynamometer (HHD) in the assessment of lower extremity strength in patients with multiple sclerosis

Detailed Description

Patients will be tested at two visits separated by 1-21 days. At each visit, the patients would undergo bilateral lower extremity strength assessment by two physical therapists, independently and in the same order. Testing would include: hip flexion, knee extension, knee flexion, ankle dorsiflexion Testing performed with 1) HHD (three trials recording maximum voluntary force) and 2) manual muscle testing (MMT), British Medical Research Council grade 0-5)

Registry
clinicaltrials.gov
Start Date
January 2015
End Date
February 2016
Last Updated
9 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Brown, Theodore R., M.D., MPH
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Stable patients with clinically definite MS, aged ≥18, EDSS of 0-7.5
  • Clinical stability defined as no MS exacerbation or change in disease modifying therapy for 30 days prior to screening.
  • EDSS as described above

Exclusion Criteria

  • Contraindications to Strength testing:
  • Inflammatory myopathy
  • Endocarditis, pericarditis or other unstable heart disease
  • Cardiac surgery or myocardial infarction in the last 3 months
  • Decompensated congestive heart failure
  • Severe aortic stenosis
  • Severe pulmonary hypertension
  • Pulmonary embolus or infarction in the last 6 months
  • Uncontrolled hypertension by history or by screening or baseline diastolic blood pressure \>170, or systolic blood pressure \> 105)
  • Marfan's syndrome

Outcomes

Primary Outcomes

To assess the intra-rater and inter-rater reliability of a hand-held dynamometer (HHD) in the assessment of lower extremity strength in patients with multiple sclerosis

Time Frame: Patients will be tested at two visits separated by 1-21 days

Inter-rater reliability intraclass correlation coefficient (ICC) combined for all observers (two observations per subject) for lower extremity Strength Sum Score (SSS)

Study Sites (1)

Loading locations...

Similar Trials